The most common side effects for both medications are gastrointestinal: nausea, vomiting, diarrhea, constipation, reflux, and abdominal discomfort
Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells
It stimulates production of endothelial nitric oxide (NO), a potent vasodilator, leading to the relaxation of blood vessels and improved coronary blood flow ( Numerous studies have proven that GLP-1 receptor agonists consistently lead to weight loss reducing appetite, enhancing fullness, slowing gastric emptying, and reducing food intake
Be fully open about your medication status during your consultation so your team can plan safely around it
It has also expanded into offering GLP-1 medication to aid weight loss in eligible people
doi: 10.1093/asj/sjae241 [DOI] [PMC free article] [PubMed] [Google Scholar] 30